In its effort to rival GSK’s shingles vaccine Shingrix, Curevo Vaccine has circled up $110 million and recruited two former ...

Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

By Kushi Arora Kentucky Health News A bill that would have banned schools and workplaces from requiring a COVID-19 vaccine or ...

As sales of its COVID vaccine plummet, Novavax is looking ahead toward other novel vaccines, brought to market with the help ...

Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...

This page is no longer being updated and reflects the status of vaccine progress through March 4, 2021. For more coverage about the pandemic, visit our coronavirus hub. 3 vaccineshave been ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

A phase-2 clinical trial for a next-generation inhaled COVID-19 vaccine has begun at McMaster University. With $8 million in funding from the Canadian Institutes of Health Research (CIHR), the ...

Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and influenza, with promising results in mice. Cornell University researchers have ...